---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-006179"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:23:17.405271+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health H1 2023 adjusted net income jumps 3550% to $3.01M, revenue down 6%

## Summary
- Q2 2023 revenue $12.36M (-6.4% YoY); H1 revenue $24.71M (-6.0% YoY) on currency headwinds.
- H1 adjusted net income $3.01M vs loss of $0.09M in H1 2022; adjusted EBITDA $3.01M (+182% YoY).
- Book value per share exceeds $4.04; stockholders' equity up 12.9% to $44.35M.
- Acquired Cana Laboratories (GMP certified) and Bikas distribution network (50 pharmacies, >$10M annual revenue expected).
- Property & equipment up 488% to $10.7M; goodwill & intangibles up 435% to $3.78M from Q4 2022.

## SEC filing metadata
- accession: 0001477932-23-006179
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223006179/0001477932-23-006179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223006179/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-006179
- JSON: https://secwatch.observer/filing/0001477932-23-006179.json
- Plain text: https://secwatch.observer/filing/0001477932-23-006179.txt

## Key facts
- Earnings Releases
  Cosmos Health Inc. reported second quarter of 2023 results: revenue $12.36 million, net income $0.16 million.
  - Period: second quarter of 2023
  - Revenue: $12.36 million
  - Net income: $0.16 million
  - Result: reported results
  source text: products, and operator of a telehealth platform, today reported its financial results for the second quarter of 2023. Q2 and H1 2023 Financial Highlights · Revenues amounted to $12.36 million in Q2 2023 and $24.71 million in H1 2023, a slight decline of 6.4% and 5.96%, respectively, from $13.21 million and $26.28 million in the corresponding periods in 2022, in part
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223006179/0001477932-23-006179-index.htm
- Earnings Releases
  Cosmos Health Inc. reported H1 2023 results: revenue $24.71 million, net income $3.01 million.
  - Period: H1 2023
  - Revenue: $24.71 million
  - Net income: $3.01 million
  - Result: reported results
  source text: Revenues amounted to $12.36 million in Q2 2023 and $24.71 million in H1 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223006179/0001477932-23-006179-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.